The FDA has approved Organon’s Vtama (tapinarof) cream, 1%, for the treatment of atopic dermatitis (AD) in adults and children as young as two years of age. According to the company, the approval was ...

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

Opens in a new tab or window Tapinarof 1% topical cream showed greater efficacy than the control in adults and children as young as age 2 years with atopic dermatitis (AD). The cream also provided ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children ... You are encouraged to report negative side effects of prescription drugs to the FDA.

"With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no ...

The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in adults and pediatric patients 2 years of age and older. An aryl ...

If you’re over 60 and you’ve started experiencing inflamed and itchy skin for the first time in your life, this could be the ...

Atopic dermatitis (AD), also called atopic eczema ... and low water content (ointments have the highest oil ratio, then ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD ... controlled with topical prescription therapies.

"With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no label ...